by: Sara Middleton, staff writer | May 6, 2022

(NaturalHealth365) Sections 8.1 and 13.1 of the drug insert for Pfizer’s FDA-approved COVID shot, COMIRNATY, feature several concerning statements: “Available data on COMIRNATY administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy.”“COMIRNATY has not been evaluated for the potential to cause carcinogenicity, genotoxicity, or impairment of male fertility.”
You must be logged in to post a comment.